René Maltais

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Knee Osteoarthritis

Molecular Docking

Endoplasmic Reticulum

Platelet Rich Plasma

Top Venues

Molecules (Basel, Switzerland)

Antioxidants (Basel, Switzerland)

The Journal of organic chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Kariminezhad, Mahdi Rahimi, Julio Fernandes, René Maltais, Jean-Yves Sancéau, Donald Poirier, Hassan Fahmi, Mohamed Benderdour
Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities. Antioxidants (Basel, Switzerland) 13 (4) (2024)
Zahra Kariminezhad, Mahdi Rahimi, Julio Fernandes, René Maltais, Jean-Yves Sancéau, Donald Poirier, Hassan Fahmi, Mohamed Benderdour
Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities. Antioxidants (Basel, Switzerland) 13 (4) (2024)
Donald Poirier, Jenny Roy, René Maltais, Cindy Weidmann, Étienne Audet-Walsh
An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models. Cancers 15 (11) (2023)
René Maltais, Jean-Yves Sancéau, Donald Poirier, André Marette
A Concise, Gram-Scale Total Synthesis of Protectin DX and Related Labeled Versions via a Key Stereoselective Reduction of Enediyne. The Journal of organic chemistry (2023)
Anna Burguin, Jenny Roy, Geneviève Ouellette, René Maltais, Juliette Bherer, Caroline Diorio, Donald Poirier, Francine Durocher
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments. Journal of clinical medicine 12 (13) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
Adrien Djiemeny Ngueta, Jenny Roy, René Maltais, Donald Poirier
Chemical Synthesis and Biological Evaluation of 3-Substituted Estrone/Estradiol Derivatives as 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors Acting via a Reverse Orientation of the Natural Substrate Estrone. Molecules (Basel, Switzerland) 28 (2) (2023)
René Maltais, Jenny Roy, Martin Perreault, Sachiko Sato, Julie-Christine Lévesque, Donald Poirier
Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel. International journal of molecular sciences 22 (20) (2021)
Donald Poirier, Jenny Roy, René Maltais
A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models. Cancers 13 (8) (2021)
Jean-Yves Sancéau, René Maltais, Donald Poirier, André Marette
Total Synthesis of the Antidiabetic (Type 2) Lipid Mediator Protectin DX/PDX. The Journal of organic chemistry 84 (2) (2018)